Telinavir

This classification denotes a protease inhibitor with the molecular formula C33H44N6O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IZF55EH3CG, chemically known as butanediamide, n1-(3-((((1,1-dimethylethyl)amino)carbonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (1s-(1r*,(r*),2s*))- but generally known as telinavir, which bears US NIH Compound Identifier 60874. European Medicines Agency schedules Telinavir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10872MIG. The term TELINAVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, No. 3, 1996, List 36). TELINAVIR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule telinavir under HS 29334910 and SITC 51575. As of Q4 2014, TELINAVIR remains the US FDA Preferred Term for this commodity. Telinavir bears US NLM identifiers UMLS ID C2699908 and NCI Concept Code C76911. SMILES: OC(C(NC(=O)C(NC(=O)C1NC2C(CC1)CCCC2)CC(=O)N)CC1CCCCC1)CN(CC(C)C)C(=O)NC(C)(C)C.